Drugs / AS012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04487860 | Jan 2021 → May 2022 | vitiligo | Ache Laboratorios Farmaceuticos S.A. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04487860 ↗ |
| Route | Oral | “oral administration” NCT04487860 ↗ |